Description: List of published materials on the topic of enterprise risk management.

Description: Employers, health plans, stop-loss insurers and reinsurers are all affected by the high cost of treating cancer. In recent years, cutting-edge pharmaceuticals, bone marrow transplants and CAR-T cell therapies have driven very high cost trends for cancer, with more emerging therapies on the horizon. In this session, we will review these new treatments, showcase models that aid in understanding the range of likely financial effects of the current, expanded, and likely-to-be approved indications for cell therapies that will treat certain patients affected by lymphoma, leukemia, and multiple myeloma. This session will explain important considerations for modeling Medicare, Medicaid versus commercial populations, key risk concerns caused by the size of enrollee pools, and important differences between the various therapies that affect modeling. We will also discuss averted cost, health outcomes, pricing levels, and risks caused by provider billing practices.

Description: 2021 Life Meeting - Session 8A: Use of Electronic Health Records in the Assessment of Life and Health Risks 9.1.21 Recording

Description: This panel discussion session focuses on the impact of double-digit inflation on pension plans including the impact on assumptions, design, prefunding of post-retirement indexing and prefunding of flat benefit plans. From Record of Society of Actuaries 1980, Vol. 6, No. 4.

Description: A paper outlining key considerations & issues that may be met when implementing VM-20, like product development resources, pricing models or product features.

Description: This article discusses the potential characteristics of health care reform and the associated impact on small insurance companies.

Description: This article discusses facts and issues related to the selection of a stock’s price distribution.

Description: From session 63 PD at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999, Impact of Regulatory Uncertainty on Product Innovation. Also discussed is the impact of XXX on policy design and reserves. This is Charts 3 and 4 from that preentation. See separate document for narrative from the presentation.

Description: Panelist discuss issues relating to new medical technologies and how these are going to affect the practice of medicine, the delivery of care, the costs of care, the insuring of care, claims handling, utilization, and cost management. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: The authors analyze the impact of the market downturn in 2008 on investors nearing retirement. The analysis finds that these investors are likely to delay retirement to recover. From the 2011 Enterprise Risk Management Symposium, March 2011.